Log in

Relevant bibliographies by topics / Leukocyte Immunoglobulin-Like Receptor B1 / Journal articles

To see the other types of publications on this topic, follow the link: Leukocyte Immunoglobulin-Like Receptor B1.

Journal articles on the topic 'Leukocyte Immunoglobulin-Like Receptor B1'

Author: Grafiati

Published: 24 May 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Leukocyte Immunoglobulin-Like Receptor B1.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Chan, K. R., E. Z. Ong, H. C. Tan, et al. "Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue." Proceedings of the National Academy of Sciences 111, no. 7 (2014): 2722–27. http://dx.doi.org/10.1073/pnas.1317454111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Lebedin, Mikhail, and Kathrin de la Rosa. "Diversification of Antibodies: From V(D)J Recombination to Somatic Exon Shuffling." Annual Review of Cell and Developmental Biology 40, no. 1 (2024): 265–81. http://dx.doi.org/10.1146/annurev-cellbio-112122-030835.

Full text

Abstract:

Antibodies that gain specificity by a large insert encoding for an extra domain were described for the first time in 2016. In malaria-exposed individuals, an exon deriving from the leukocyte-associated immunoglobulin-like 1 (LAIR1) gene integrated via a copy-and-paste insertion into the immunoglobulin heavy chain encoding region. A few years later, a second example was identified, namely a dual exon integration from the leukocyte immunoglobulin-like receptor B1 (LILRB1) gene that is located in close proximity to LAIR1. A dedicated high-throughput characterization of chimeric immunoglobulin hea

APA, Harvard, Vancouver, ISO, and other styles

3

Rafiei, Anahita, Marco Gualandi, Chia-Lung Yang, et al. "IOS-1002, a Stabilized HLA-B57 Open Format, Exerts Potent Anti-Tumor Activity." Cancers 16, no. 16 (2024): 2902. http://dx.doi.org/10.3390/cancers16162902.

Full text

Abstract:

HLA-B27 and HLA-B57 are associated with autoimmunity and long-term viral control and protection against HIV and HCV infection; however, their role in cancer immunity remains unknown. HLA class I molecules interact with innate checkpoint receptors of the LILRA, LILRB and KIR families present in diverse sets of immune cells. Here, we demonstrate that an open format (peptide free conformation) and expression- and stability-optimized HLA-B57-B2m-IgG4_Fc fusion protein (IOS-1002) binds to human leukocyte immunoglobulin-like receptor B1 and B2 (LILRB1 and LILRB2) and to killer immunoglobulin-like re

APA, Harvard, Vancouver, ISO, and other styles

4

Huang, Luofei, Han Li, and Quanzhi Lin. "Identification of key genes and diagnostic biomarkers for peripheral atherosclerosis: A multi-omics approach." Medicine 104, no. 21 (2025): e42437. https://doi.org/10.1097/md.0000000000042437.

Full text

Abstract:

Peripheral atherosclerosis (PAS), characterized by lipid plaque accumulation in arterial walls, significantly increases cardiovascular risk. This study aimed to identify molecular biomarkers and elucidate underlying mechanisms of PAS progression. We analyzed 2 gene expression omnibus datasets (GSE28829, GSE100927) to identify differentially expressed genes (P < .05, |log2FC| ≥ 0.585). Functional enrichment (Gene Ontology/Kyoto Encyclopedia of Genes and Genomes) and Mendelian randomization analyses were performed using genome-wide association study and expression quantitative trait loci data

APA, Harvard, Vancouver, ISO, and other styles

5

Cadena-Mota, Sandra, Adriana Monsiváis-Urenda, Mariana Salgado-Bustamante, et al. "Effect of cytomegalovirus infection and leukocyte immunoglobulin like receptor B1 polymorphisms on receptor expression in peripheral blood mononuclear cells." Microbiology and Immunology 62, no. 12 (2018): 755–62. http://dx.doi.org/10.1111/1348-0421.12661.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Truong, Anh Duc, Yeojin Hong, Janggeun Lee, et al. "Chicken novel leukocyte immunoglobulin-like receptor subfamilies B1 and B3 are transcriptional regulators of major histocompatibility complex class I genes and signaling pathways." Asian-Australasian Journal of Animal Sciences 32, no. 5 (2019): 614–28. http://dx.doi.org/10.5713/ajas.18.0561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kuroki, Kimiko, Sayoko Kobayashi, Mitsunori Shiroishi, et al. "Detection of weak ligand interactions of leukocyte Ig-like receptor B1 by fluorescence correlation spectroscopy." Journal of Immunological Methods 320, no. 1-2 (2007): 172–76. http://dx.doi.org/10.1016/j.jim.2006.11.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Shiroishi, Mitsunori, Kimiko Kuroki, Kouhei Tsumoto, et al. "Entropically Driven MHC Class I Recognition by Human Inhibitory Receptor Leukocyte Ig-like Receptor B1 (LILRB1/ILT2/CD85j)." Journal of Molecular Biology 355, no. 2 (2006): 237–48. http://dx.doi.org/10.1016/j.jmb.2005.10.057.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ryan, D., S. Kossover, S. Mitchell, C. Frantz, L. Hennessy, and H. Cohen. "Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens." Blood 68, no. 2 (1986): 417–25. http://dx.doi.org/10.1182/blood.v68.2.417.417.

Full text

Abstract:

Abstract Bone marrow samples from normal adults and children with nonhematologic malignancies not involving the marrow, acute lymphoblastic leukemia (ALL) in continued remission, and immune cytopenias were studied by two- color immunofluorescence (IF) and flow cytometry to characterize common acute lymphoblastic leukemia antigen (CALLA)-positive marrow lymphoid cells. Marrow was separated by Ficoll/Hypaque centrifugation followed by passage over a monoclonal antibody affinity column to remove myeloid cells prior to IF staining. A higher proportion of CALLA-positive cells was found in the pedia

APA, Harvard, Vancouver, ISO, and other styles

10

Ryan, D., S. Kossover, S. Mitchell, C. Frantz, L. Hennessy, and H. Cohen. "Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens." Blood 68, no. 2 (1986): 417–25. http://dx.doi.org/10.1182/blood.v68.2.417.bloodjournal682417.

Full text

Abstract:

Bone marrow samples from normal adults and children with nonhematologic malignancies not involving the marrow, acute lymphoblastic leukemia (ALL) in continued remission, and immune cytopenias were studied by two- color immunofluorescence (IF) and flow cytometry to characterize common acute lymphoblastic leukemia antigen (CALLA)-positive marrow lymphoid cells. Marrow was separated by Ficoll/Hypaque centrifugation followed by passage over a monoclonal antibody affinity column to remove myeloid cells prior to IF staining. A higher proportion of CALLA-positive cells was found in the pediatric marr

APA, Harvard, Vancouver, ISO, and other styles

11

Khanolkar, Rahul C., Michail Kalogeropoulos, Alistair Lawrie, Ali Roghanian, Mark A. Vickers та Neil T. Young. "Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1". Journal of Leukocyte Biology 100, № 4 (2016): 737–46. http://dx.doi.org/10.1189/jlb.1a0915-420rrr.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Bassan, David, Leehee Weinberger, Jason Yi, et al. "HER2 and HLA-A*02 dual CAR-T cells utilize LOH in a NOT logic gate to address on-target off-tumor toxicity." Journal for ImmunoTherapy of Cancer 11, no. 12 (2023): e007426. http://dx.doi.org/10.1136/jitc-2023-007426.

Full text

Abstract:

BackgroundOne of the major challenges in chimeric antigen receptor (CAR)-T cell therapy for solid tumors is the potential for on-target off-tumor toxicity due to the expression of CAR tumor antigens in essential tissues and organs. Here, we describe a dual CAR NOT gate incorporating an inhibitory CAR (iCAR) recognizing HLA-A*02 (“A2”) that enables effective treatment with a potent HER2 activating CAR (aCAR) in the context of A2 loss of heterozygosity (LOH).MethodsA CAR-T cell screen was conducted to identify inhibitory domains derived from natural immune receptors (iDomains) to be used in a NO

APA, Harvard, Vancouver, ISO, and other styles

13

Vojvodić, Svetlana, and D. Ademović-Sazdanić. "KIR And HLA Haplotype Analysis in a Family Lacking The KIR 2DL1-2DP1 Genes." Balkan Journal of Medical Genetics 18, no. 1 (2015): 55–64. http://dx.doi.org/10.1515/bjmg-2015-0006.

Full text

Abstract:

Abstract The killer cell immunoglobulin-like receptor (KIR) gene cluster exhibits extensive allelic and haplotypic diversity that is observed as presence/absence of genes, resulting in expansion and contraction of KIR haplotypes and by allelic variation of individual KIR genes. We report a case of KIR pseudogene 2DP1 and 2DL1 gene absence in members of one family with the children suffering from acute myelogenous leukemia (AML). Killer cell immunoglo-bulin-like receptor low resolution genotyping was performed by the polymerase chain reaction (PCR)-sequencespecific primers (SSP)/sequence-specif

APA, Harvard, Vancouver, ISO, and other styles

14

Gazdar, AF, HK Oie, IR Kirsch, and GF Hollis. "Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene." Blood 67, no. 6 (1986): 1542–49. http://dx.doi.org/10.1182/blood.v67.6.1542.1542.

Full text

Abstract:

Abstract Using a serum-free defined medium, we have established a human cell line, NCI-H929, from a malignant effusion occurring in a patient with IgAk myeloma. The cultured cells have the morphologic, ultrastructural, biochemical, immunologic, and cytochemical features of plasma cells. The cells have rearranged alpha and kappa genes and synthesize and secrete high amounts of IgAk (greater than 80 micrograms/10(6) cells per 24 hours). The cells express surface immunoglobulin (alpha and kappa), the plasma cell antigen PCA-1, the transferrin receptor (T9) and T10 but lack antigens associated wit

APA, Harvard, Vancouver, ISO, and other styles

15

Gazdar, AF, HK Oie, IR Kirsch, and GF Hollis. "Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene." Blood 67, no. 6 (1986): 1542–49. http://dx.doi.org/10.1182/blood.v67.6.1542.bloodjournal6761542.

Full text

Abstract:

Using a serum-free defined medium, we have established a human cell line, NCI-H929, from a malignant effusion occurring in a patient with IgAk myeloma. The cultured cells have the morphologic, ultrastructural, biochemical, immunologic, and cytochemical features of plasma cells. The cells have rearranged alpha and kappa genes and synthesize and secrete high amounts of IgAk (greater than 80 micrograms/10(6) cells per 24 hours). The cells express surface immunoglobulin (alpha and kappa), the plasma cell antigen PCA-1, the transferrin receptor (T9) and T10 but lack antigens associated with earlier

APA, Harvard, Vancouver, ISO, and other styles

16

Wang, Juncheng, Housaiyin Li, Aditi Kulkarni, et al. "Differential impact of TIM-3 ligands on NK cell function." Journal for ImmunoTherapy of Cancer 13, no. 1 (2025): e010618. https://doi.org/10.1136/jitc-2024-010618.

Full text

Abstract:

BackgroundThe transmembrane protein T-cell immunoglobulin and mucin-domain containing molecule 3 (TIM-3) is an immune checkpoint receptor that is expressed by a variety of leukocyte subsets, particularly in the tumor microenvironment. An effective TIM-3-targeting therapy should account for multiple biological factors, including the disease setting, the specific cell types involved and their varying sensitivities to the four putative TIM-3 ligands (galectin-9, phosphatidylserine, high mobility group protein B1 and carcinoembryonic antigen cell adhesion molecule 1), each of which engages a uniqu

APA, Harvard, Vancouver, ISO, and other styles

17

Xian, Miao, Qing Yi, Qiang Wang, et al. "Abstract 364: Targeting LILRB1 to sensitize human myeloma to ferroptosis through disrupting cholesterol homeostasis." Cancer Research 84, no. 6_Supplement (2024): 364. http://dx.doi.org/10.1158/1538-7445.am2024-364.

Full text

Abstract:

Abstract Multiple myeloma (MM) is a hematologic malignancy characterized by the uncontrolled clonal proliferation of plasma cells in the bone marrow (BM). Despite the demonstrated benefits of novel therapies, relapses are frequent, and acquired resistance to MM treatment eventually emerges in most, if not all, patients. MM patients who suffer more aggressive progression usually result in poorer survival. The genes driving such unfavored outcomes in MM have not been fully understood. Therefore, there is an urgent need to identify the genes and mechanisms that contribute to the aggressive behavi

APA, Harvard, Vancouver, ISO, and other styles

18

Deng, Mi, Heyu Chen, Xiaoye Liu, et al. "Leukocyte immunoglobulin-like receptor subfamily B: therapeutic targets in cancer." Antibody Therapeutics 4, no. 1 (2021): 16–33. http://dx.doi.org/10.1093/abt/tbab002.

Full text

Abstract:

Abstract Inhibitory leukocyte immunoglobulin-like receptors (LILRBs 1–5) transduce signals via intracellular immunoreceptor tyrosine-based inhibitory motifs that recruit phosphatases to negatively regulate immune activation. The activation of LILRB signaling in immune cells may contribute to immune evasion. In addition, the expression and signaling of LILRBs in cancer cells especially in certain hematologic malignant cells directly support cancer development. Certain LILRBs thus have dual roles in cancer biology—as immune checkpoint molecules and tumor-supporting factors. Here, we review the e

APA, Harvard, Vancouver, ISO, and other styles

19

Tedla, N., C. Bandeira-Melo, P. Tassinari, et al. "Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7." Proceedings of the National Academy of Sciences 100, no. 3 (2003): 1174–79. http://dx.doi.org/10.1073/pnas.0337567100.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Mandel, Ilana, Rui Wang, Anne Caron, et al. "Evaluation of pharmacodynamic and patient enrichment biomarkers for SAR444881, a first-in-class anti-ILT2 monoclonal antibody for cancer immunotherapy." Journal of Clinical Oncology 40, no. 16_suppl (2022): 2571. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.2571.

Full text

Abstract:

2571 Background: Leukocyte Ig-like receptor B1 [LILRB1; ILT2] is an inhibitory receptor expressed on various immune cells. ILT2 binds to classical and nonclassical MHC class I molecules, with highest affinity to HLA-G. ILT2-mediated inhibition leads to impairment of immune cell proliferation, differentiation, phagocytosis, cytotoxicity and cytokine secretion. Antagonism of ILT2 signaling may serve as a novel target for anti-cancer immunotherapy. SAR444881 (BND-22) is a novel humanized IgG4 monoclonal antagonist antibody which selectively binds to ILT2 and blocks its interaction with MHC I mole

APA, Harvard, Vancouver, ISO, and other styles

21

Zhao, Wen-Zhuo, Hong-Gang Wang, and Xiao-Zhong Yang. "Leukocyte immunoglobulin-like receptor B2: A promising biomarker for colorectal cancer." World Journal of Gastroenterology 30, no. 4 (2024): 421–23. http://dx.doi.org/10.3748/wjg.v30.i4.421.

Full text

Abstract:

According to the latest global cancer statistics, colorectal cancer (CRC) has emerged as the third most prevalent malignant tumor across the globe. In recent decades, the medical field has implemented several levels of CRC screening tests, encompassing fecal tests, endoscopic examinations, radiological examinations and blood tests. Previous studies have shown that leukocyte immunoglobulin-like receptor B2 (LILRB2) is involved in inhibiting immune cell function, immune evasion, and promoting tumor progression in acute myeloid leukemia and non-small cell lung cancer. However, its interaction wit

APA, Harvard, Vancouver, ISO, and other styles

22

Zhou, Long, Jennifer M. Hinerman, Michal Blaszczyk, et al. "Structural basis for collagen recognition by the immune receptor OSCAR." Blood 127, no. 5 (2016): 529–37. http://dx.doi.org/10.1182/blood-2015-08-667055.

Full text

Abstract:

Key Points OSCAR has 2 immunoglobulin-like domains with an obtuse interdomain angle, differing from other members of the leukocyte receptor cluster. Each domain of OSCAR binds a collagen triple-helical peptide; the primary site is on the C-terminal domain in contrast to GPVI and LAIR-1.

APA, Harvard, Vancouver, ISO, and other styles

23

Enomoto, Yutaka, Yoshinori Yamanishi, Kumi Izawa, et al. "Characterization of Leukocyte Mono-immunoglobulin-like Receptor 7 (LMIR7)/CLM-3 as an Activating Receptor." Journal of Biological Chemistry 285, no. 46 (2010): 35274–83. http://dx.doi.org/10.1074/jbc.m110.137166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Liu, W. Robert, Joomyeong Kim, Chioma Nwankwo, Linda K. Ashworth, and J. P. Arm. "Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on Chromosome 19q13.4." Immunogenetics 51, no. 8-9 (2000): 659–69. http://dx.doi.org/10.1007/s002510000183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Jelčić, Ilijas, Katharine C. Hsu, Kristina Kakalacheva, et al. "Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis." Multiple Sclerosis Journal 18, no. 7 (2011): 951–58. http://dx.doi.org/10.1177/1352458511431726.

Full text

Abstract:

Objective: The objective of this study was to analyze whether inhibitory and activating killer cell immunoglobulin-like receptors (KIRs) and human leukocyte antigen (HLA) class I alleles defined by their KIR binding motifs are associated with multiple sclerosis (MS) susceptibility or severity. Method: We performed a population-based case–control study in 321 patients with clinically isolated syndrome (CIS) and clinically definite MS (CDMS) and 156 healthy blood donors (HD). Inhibitory and activating KIRs and HLA class I alleles were genotyped using polymerase chain reaction (PCR) sequence-spec

APA, Harvard, Vancouver, ISO, and other styles

26

Sloane, David E., Nicodemus Tedla, Muyiwa Awoniyi, et al. "Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition." Blood 104, no. 9 (2004): 2832–39. http://dx.doi.org/10.1182/blood-2004-01-0268.

Full text

Abstract:

Abstract Basophils, recruited from the blood to tissues, have been implicated by their presence in diverse allergic disorders including bronchial asthma, allergic rhinitis, and cutaneous contact hypersensitivity. We hypothesized that like other leukocytes involved in inflammatory responses, basophils would express members of the leukocyte immunoglobulin-like receptor (LIR) family of immuno-regulatory molecules on their cell surface. We identified LIR7, an activating member coupled to the common Fc receptor gamma chain, and LIR3, an inhibitory member containing cytoplasmic immunoreceptor tyrosi

APA, Harvard, Vancouver, ISO, and other styles

27

Hansell, Chris A. H., Chris Schiering, Ross Kinstrie, et al. "Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice." Blood 117, no. 20 (2011): 5413–24. http://dx.doi.org/10.1182/blood-2010-11-317115.

Full text

Abstract:

Abstract Mouse innate-like B cells are a heterogeneous collection of multifunctional cells that control infection, play housekeeping roles, contribute to adaptive immunity, and suppress inflammation. We show that, among leukocytes, chemokine internalization by the D6 receptor is a unique and universal feature of all known innate-like B-cell populations and, to our knowledge, the most effective unifying marker of these cells. Moreover, we identify novel D6active B1-cell subsets, including those we term B1d, which lack CD5 and CD11b but exhibit typical B1-cell properties, including spontaneous e

APA, Harvard, Vancouver, ISO, and other styles

28

Simon, Hogan, Haberman Yael, Waggoner Lisa, Barski Artem, Munitz Ariel, and Denson Lee. "O-034 Novel Isoforms of Leukocyte Immunoglobulin Like Receptor B3 in Pediatric UC." Inflammatory Bowel Diseases 20 (December 2014): S18. http://dx.doi.org/10.1097/01.mib.0000456692.24223.64.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Vivian, Julian P., Renee C. Duncan, Richard Berry, et al. "Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B." Nature 479, no. 7373 (2011): 401–5. http://dx.doi.org/10.1038/nature10517.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

SHIROISHI, Mitsunori, Kimiko KUROKI, Daisuke KOHDA, and Katsumi MAENAKA. "Entropically Driven Receptor-Ligand Interaction; Molecular Recognition of Human Inhibitory Receptor Leukocyte Immunoglobulin-Like Receptors (LILRs)." Seibutsu Butsuri 47, no. 2 (2007): 093–99. http://dx.doi.org/10.2142/biophys.47.093.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Agrawal, S., S. Alam, D. Rangaswamy, et al. "Impact of killer immunoglobulin-like receptor-human leukocyte antigens ligand incompatibility among renal transplantation." Indian Journal of Nephrology 25, no. 1 (2015): 27. http://dx.doi.org/10.4103/0971-4065.134655.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Li, Juan, Liyou Xu, Xinwen Li, et al. "Expression of leukocyte immunoglobulin-like receptor B2 in hepatocellular carcinoma and its clinical significance." Journal of Cancer Research and Therapeutics 14, no. 7 (2018): 1655. http://dx.doi.org/10.4103/jcrt.jcrt_542_18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Wang, Yue, Xueshan Zhang, Fang Miao, et al. "Clinical significance of leukocyte-associated immunoglobulin-like receptor-1 expression in human cervical cancer." Experimental and Therapeutic Medicine 12, no. 6 (2016): 3699–705. http://dx.doi.org/10.3892/etm.2016.3842.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Hirayasu, Kouyuki, and Hisashi Arase. "Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations." Journal of Human Genetics 60, no. 11 (2015): 703–8. http://dx.doi.org/10.1038/jhg.2015.64.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Norman, Paul J., B. Sean Carey, Henry A. F. Stephens, and Robert W. Vaughan. "DNA sequence variation and molecular genotyping of natural killer leukocyte immunoglobulin-like receptor, LILRA3." Immunogenetics 55, no. 3 (2003): 165–71. http://dx.doi.org/10.1007/s00251-003-0561-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Yang, Jian. "LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR B4 PROMOTES MYOCARDIAL ISCHEMIA-REPERFUSION INJURY VIA SHP1-STAT3 PATHWAY." Journal of the American College of Cardiology 81, no. 8 (2023): 1166. http://dx.doi.org/10.1016/s0735-1097(23)01610-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Haywood, Joel, Jianxun Qi, Chun-Chi Chen, et al. "Structural basis of collagen recognition by human osteoclast-associated receptor and design of osteoclastogenesis inhibitors." Proceedings of the National Academy of Sciences 113, no. 4 (2016): 1038–43. http://dx.doi.org/10.1073/pnas.1522572113.

Full text

Abstract:

Human osteoclast-associated receptor (OSCAR) is an immunoglobulin (Ig)-like collagen receptor that is up-regulated on osteoclasts during osteoclastogenesis and is expressed in a range of myeloid cells. As a member of the leukocyte receptor complex family of proteins, OSCAR shares a high degree of sequence and structural homology with other collagen receptors of this family, including glycoprotein VI, leukocyte-associated Ig-like receptor-1, and leukocyte Ig-like receptor B4, but recognizes a unique collagen sequence. Here, we present the crystal structures of OSCAR in its free form and in comp

APA, Harvard, Vancouver, ISO, and other styles

38

Torkar, Michaela, Zoë Norgate, Marco Colonna, John Trowsdale, and Michael J. Wilson. "Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex." European Journal of Immunology 28, no. 12 (1998): 3959–67. http://dx.doi.org/10.1002/(sici)1521-4141(199812)28:12<3959::aid-immu3959>3.0.co;2-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Matsukawa, Toshihiro, Takanori Teshima, Ko Okumura, and Jiro Kitaura. "An inhibitory receptor leukocyte mono-immunoglobulin-like receptor 3/CD300f deficiency aggravates DSS-induced colitis (MUC8P.737)." Journal of Immunology 194, no. 1_Supplement (2015): 204.17. http://dx.doi.org/10.4049/jimmunol.194.supp.204.17.

Full text

Abstract:

Abstract Leukocyte mono-immunoglobulin-like receptor 3 (LMIR3) (also called CD300f) is an inhibitory receptor. LMIR3 is mainly expressed in myeloid cells, including mast cells. The binding of LMIR3 to its ligand ceramide inhibits IgE- and mast cell-dependent allergic responses. It was recently reported that ATP-induced activation of mast cells via P2X7 purinoceptor contributes to the initiation and progression of intestinal inflammation. Here we show that LMIR3 is a negative regulator of dextran sodium sulfate (DSS)-induced colitis, a murine model of ulcerative colitis (UC). Notably, Lmir3-/-

APA, Harvard, Vancouver, ISO, and other styles

40

Berger, S. A., T. W. Mak, and C. J. Paige. "Leukocyte common antigen (CD45) is required for immunoglobulin E-mediated degranulation of mast cells." Journal of Experimental Medicine 180, no. 2 (1994): 471–76. http://dx.doi.org/10.1084/jem.180.2.471.

Full text

Abstract:

We demonstrate using primary mast cell cultures derived from wild-type and CD45-deficient mice that mast cell triggering through the high-affinity immunoglobulin E (IgE) receptor requires the cell surface tyrosine phosphatase CD45. Unlike wild-type cells, cross-linking of surface-bound IgE in mast cells deficient in CD45 does not induce degranulation. Degranulation in these mutant cells does occur after treatment with the calcium ionophore A23187 indicating that the degranulation machinery is intact in these cells. We also demonstrate that the tyrosine phosphatase inhibitors orthoVanadate and

APA, Harvard, Vancouver, ISO, and other styles

41

Al Turkestani, Najla, Zhaocheng Zhang, and Jacques Eduardo Nör. "Semaphorin 4D Induces Vasculogenic Differentiation of Dental Pulp Stem Cells." Dentistry Journal 11, no. 7 (2023): 160. http://dx.doi.org/10.3390/dj11070160.

Full text

Abstract:

This work aimed to evaluate the effect of Semaphorin 4D (SEMA4D) signaling through Plexin B1 on the vasculogenic differentiation of dental pulp stem cells. We assessed the protein expression of SEMA4D and Plexin B1 in dental pulp stem cells (DPSC) from permanent human teeth and stem cells from human exfoliated deciduous (SHED) teeth using Western blots. Their expression in human dental pulp tissues and DPSC-engineered dental pulps was determined using immunofluorescence. We then exposed dental pulp stem cells to recombinant human SEMA4D (rhSEMA4D), evaluated the expression of endothelial cell

APA, Harvard, Vancouver, ISO, and other styles

42

Fan, Jing, Jiayan Li, Jianbo Han, et al. "Expression of leukocyte immunoglobulin-like receptor subfamily B expression on immune cells in hepatocellular carcinoma." Molecular Immunology 136 (August 2021): 82–97. http://dx.doi.org/10.1016/j.molimm.2021.05.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zhang, Shuang, Xu Ma, and Jin Fu. "Silencing Leukocyte Immunoglobulin-Like Receptor A1 in Monocytes Inhibits Inflammation in Mice with Multiple Sclerosis." Neuroimmunomodulation 26, no. 2 (2019): 93–101. http://dx.doi.org/10.1159/000495625.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Davidson, Chelsea L., Lisa E. Cameron, and Deborah N. Burshtyn. "The AP-1 transcription factor JunD activates the leukocyte immunoglobulin-like receptor 1 distal promoter." International Immunology 26, no. 1 (2013): 21–33. http://dx.doi.org/10.1093/intimm/dxt038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Perumbeti, Ajay, Alin Girnita, and Jose A. Cancelas. "Leukocyte Immunoglobulin-Like Receptor B Regulates Erythroblastic Island Size in Human in-Vitro Erythroblastic Islands." Blood 120, no. 21 (2012): 3190. http://dx.doi.org/10.1182/blood.v120.21.3190.3190.

Full text

Abstract:

Abstract Abstract 3190 Erythropoiesis occurs in a unique bone marrow (BM) microenvironment known as erythroblastic islands. Erythroblastic islands are composed of erythroid precursors in close contact with specialized stromal macrophages, also referred to as central or island macrophages. Human erythroblastic island macrophages have been difficult to discern from other macrophage subpopulations by cell surface markers, although they have reduced expression of C3b receptor (CD35) (Lee et al., 1988). The unique non-antigen presenting nature of erythroblastic island macrophages led us to hypothes

APA, Harvard, Vancouver, ISO, and other styles

46

Zhang, Zhiyong, Hiroko Hatano, Jacqueline Shaw, et al. "The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains." PLOS ONE 10, no. 6 (2015): e0129063. http://dx.doi.org/10.1371/journal.pone.0129063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Zhang, Chunbin, Nagamasa Maeda, Chiaki Izumiya, et al. "Killer Immunoglobulin-like Receptor and Human Leukocyte Antigen Expression as Immunodiagnostic Parameters for Pelvic Endometriosis." American Journal of Reproductive Immunology 55, no. 2 (2006): 106–14. http://dx.doi.org/10.1111/j.1600-0897.2005.00332.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Kartal, Ozgur, Ugur Musabak, Sait Yesillik, et al. "Killer-cell immunoglobulin-like receptor and human leukocyte antigen-C genes in common variable immunodeficiency." Wiener klinische Wochenschrift 128, no. 21-22 (2015): 822–26. http://dx.doi.org/10.1007/s00508-015-0769-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Dorando, Hannah K., Helen Rich, Helen Warheit-Niemi, et al. "Leukocyte associated immunoglobulin-like receptor 1 modulates immune response to Staphylococcus aureusinfection." Journal of Immunology 210, no. 1_Supplement (2023): 72.35. http://dx.doi.org/10.4049/jimmunol.210.supp.72.35.

Full text

Abstract:

Abstract Immunity is a balance of maximal pathogen defense with minimal host damage. Inhibitory immune receptors are important for maintaining this balance. We recently identified elevated levels of leukocyte-associated immunoglobulin (Ig)-like receptor protein1 (LAIR1), an inhibitory immune receptor, in cutaneous lymphoma patients, in whom invasive Staphylococcus aureus (S. aureus) infections are frequent. We therefore tested Lair1 knock-out (KO) mice in two models of invasive S. aureus infection: pneumonia and subcutaneous skin infection. In WT mice, skin infections resolve by 14 days post-i

APA, Harvard, Vancouver, ISO, and other styles

50

Yamashita, T., K. Shinohara, and Y. Yamashita. "Expression cloning of complementary DNA encoding three distinct isoforms of guinea pig Fc receptor for IgG1 and IgG2." Journal of Immunology 151, no. 4 (1993): 2014–23. http://dx.doi.org/10.4049/jimmunol.151.4.2014.

Full text

Abstract:

Abstract Three cDNA clones encoding the guinea pig Fc receptor for IgG1 and IgG2 (Fc gamma 1/gamma 2 R) have been isolated by an expression cloning strategy using mAb directed against the receptor. When transfected into COS-7 cells, these cDNA induced cell surface expression of the receptor that bound IgG1 and IgG2 antibodies complexed with the Ag. The ligand-binding affinities of these receptors were indistinguishable. Nucleotide sequencing has indicated that one of these clones, Fc gamma 1/gamma 2R-B1, is identical to the previously isolated cDNA clone homologous to the b2 isoform of human F

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!